• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Centene Corporation filed SEC Form 8-K: Leadership Update

    3/24/26 5:15:16 PM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email
    cnc-20260318
    0001071739false00010717392026-03-182026-03-18



    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): March 18, 2026

    CENTENE CORPORATION
    (Exact Name of Registrant as Specified in Charter)

    Delaware001-3182642-1406317
    (State or Other Jurisdiction
    of Incorporation)
    (Commission File Number)
    (IRS Employer
    Identification No.)
    7700 Forsyth Boulevard,
    St. Louis,Missouri63105
    (Address of Principal Executive Offices)(Zip Code)
    Registrant’s telephone number, including area code: (314) 725-4477
    (Former Name or Former Address, if Changed Since Last Report): N/A
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, $0.001 Par Value
    CNC
    New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

    Effective March 18, 2026, the Board of Directors (the Board) of Centene Corporation (the Company) appointed Theodore Pienkos, 44, a registered CPA, to serve as the Company's Corporate Controller and Chief Accounting Officer. Mr. Pienkos previously has served as the Company's Deputy Corporate Controller since August 2024. Prior to that, he served as Vice President of Finance & Accounting from August 2017 to August 2024, and he has held other accounting roles of increasing importance with Centene since March 2011. Before joining Centene, Mr. Pienkos served as an auditor for KPMG LLP from August 2004 to March 2011. He holds a BA and MA in Accounting from the University of Northern Iowa.

    In connection with this appointment, he will receive a base salary of $440,000 and have a target bonus of 60% of the base salary. He will continue to participate in the Company's incentive compensation programs and he will receive benefits as set forth in the Company's executive severance plan.

    There are no family relationships between Mr. Pienkos and any director or executive officer of the Company. There are no related party transactions in respect of the Company of the kind described in Item 404(a) of Regulation S-K in which Mr. Pienkos was a participant.

    Consistent with our efforts around intentional leadership development, Kate Casso, who has been with the Company for over two decades and served as the Company's prior Corporate Controller and Chief Accounting Officer since April 2021, has been appointed Senior Vice President, Finance Operations and Innovation, effective as of March 18, 2026. In this role, Ms. Casso will devote part of her time to innovation, both enterprise-wide and within Finance, while continuing to lead Data Analytics, Medical Economics, Payment Integrity, Finance Shared Services, Financial Planning and Analysis, and other various Finance teams.



    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    CENTENE CORPORATION
    Date:March 24, 2026By:/s/ Christopher A. Koster
    Christopher A. Koster
    Executive Vice President, Secretary and General Counsel



    Get the next $CNC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    6/23/2026$70.00Sector Perform
    RBC Capital Mkts
    5/20/2026$80.00Hold → Buy
    Deutsche Bank
    4/29/2026$60.00Neutral → Overweight
    Cantor Fitzgerald
    4/29/2026$60.00Underperform → Buy
    BofA Securities
    1/5/2026$54.00Equal Weight → Overweight
    Barclays
    10/14/2025$33.00Sell
    Goldman
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $CNC
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CENTENE CORP (0001071739) (Filer)

    6/22/26 4:37:20 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Leadership Update

    8-K - CENTENE CORP (0001071739) (Filer)

    5/15/26 4:06:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CENTENE CORP (0001071739) (Filer)

    4/27/26 8:08:15 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, July 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 4306002 to expedite caller registration; or via a live,

    7/10/26 8:45:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE SUBSIDIARY MERIDIAN HEALTH PLAN OF ILLINOIS AWARDED ILLINOIS MEDICAID CONTRACT

    ST. LOUIS, July 9, 2026 /PRNewswire/ -- Centene Corporation (Centene) (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing services for the HealthChoice Illinois Medicaid managed care program. The four-year contract is expected to begin January 1, 2027, through 2030. "Centene has a long track record serving Medicaid and dually eligible Medicaid-Medicare members in Illinois," said Chief E

    7/9/26 7:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Health Net Providing Special Assistance to Members and Providers Affected by Palos Warehouse Fire in Los Angeles

    SACRAMENTO, Calif., June 23, 2026 /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in Los Angeles County, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is taking immediate action to support those affected by the fire. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time. Member Prescription InformationDuring a declared State of Emergency, impacted members have two options to secure an emergency supply of their medications:Members can fill t

    6/23/26 1:35:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Centene with a new price target

    RBC Capital Mkts initiated coverage of Centene with a rating of Sector Perform and set a new price target of $70.00

    6/23/26 8:23:13 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Centene from Hold to Buy and set a new price target of $80.00

    5/20/26 8:03:29 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene upgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald upgraded Centene from Neutral to Overweight and set a new price target of $60.00

    4/29/26 7:59:54 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tyler Lauren M was granted 3,155 shares, increasing direct ownership by 5,172% to 3,216 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/20/26 4:45:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Tyler Lauren M was granted 61 shares (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/1/26 5:47:29 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii was granted 465 shares, increasing direct ownership by 2% to 25,213 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/1/26 5:47:18 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    View All

    CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS

    ST. LOUIS, June 22, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. Ms. Tyler will serve on the Audit Committee and Compensation and Talent Committee. Ms. Tyler brings more than 30 years of leadership experience across investment banking, private equity, corporate audit, investor relations, and human capital strategy."Lauren's longstanding track record guiding global, complex organizations through transformation while prioritizing governance, talent development, and operati

    6/22/26 4:30:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Announces New Executive Leadership Structure

    Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty  ST. LOUIS, April 6, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty. "We are pl

    4/6/26 7:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, July 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 4306002 to expedite caller registration; or via a live,

    7/10/26 8:45:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2026 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL

    ST. LOUIS, April 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 first quarter financial results at approximately 6:00 a.m. ET on Tuesday, April 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 0526

    4/10/26 9:48:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE

    -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD

    2/6/26 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care